AMG Appoints G. Staley Cates to its Board of Directors Karen L. Alvingham to Retire from Board of Directors WEST PALM BEACH, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment of G. Staley Cates to its Board of Directors (the “Board”), effective April 1, 2026; the Company also announced the forthcoming retirement of Karen L. Alvingham from the Board, effective April 1, 2026. Lady Alvingham was appointed to AMG’s Board of Directors in January 2018. Mr. Cates served as the Vice Chai...
AMG Reports Financial and Operating Results for the Fourth Quarter and Full Year 2025 Company reports Diluted EPS of $11.21, Economic EPS of $9.48 in the fourth quarter of 2025Diluted EPS of $22.74, Economic EPS of $26.05 for the full year 2025 Net client cash inflows of approximately $29 billion in 2025, including approximately $12 billion in the fourth quarter, driven by ongoing momentum in alternative strategiesFull-year Net income (controlling interest) of $717 million, Economic net income (controlling interest) of $769 millionFull-year Economic EPS of $26.05 increased 22% year-over-ye...
AMG Expands Its Partnership with Garda Capital Partners with Increased Investment Increased investment deepens AMG’s partnership with Garda, a leading liquid alternatives manager specializing in fixed income relative value, with an excellent long-term investment track recordGarda will remain majority-owned and led by its management teamTransaction is aligned with AMG’s long-term growth strategy and further expands Company’s exposure to alternative strategies through an increased investment in an attractive, differentiated liquid alternatives manager WEST PALM BEACH, Fla., Feb. 12, 2026 (...
AMG Announces Partnership with HighBrook Investors AMG invests in HighBrook, a real estate investment manager specializing in thematic value-add opportunities in the U.S. and EuropeHighBrook to leverage AMG’s strategic capabilities to enhance its long-term success and continue to build an enduring firmPartnership further diversifies AMG’s business and expands its participation in global private markets WEST PALM BEACH, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced its acquisition of a minorit...
Moody's Ratings (Moody's) today affirmed Coty Inc.'s ("Coty") Ba1 Corporate Family Rating ("CFR"), Ba1-PD Probability of Default Rating, Ba1 senior secured first lien revolving credit facility rating, Ba1 senior secured ratings, and Ba1 senior unsecured ratings. Coty's SGL-2 speculative grade liquid...
AMG to Announce Fourth-Quarter and Full-Year Results on February 12, 2026 Conference Call Scheduled for 8:30 a.m. Eastern Time WEST PALM BEACH, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 12, 2026. A conference call will be held at 8:30 a.m. Eastern time on the same day. In addition to quarterly results, the conference call may include discussion of management’s expectations of future financial and operating results. Jay C. Horgen, Chief Execut...
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 CHAPEL HILL, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, announced today that the Company will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026, which is taking place from February 11-12, 2026, in New York, NY. Details of presentation:Format: Fireside chatPar...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Golub Capital BDC, Inc. (GBDC) and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 7 January 2026 in which we reassessed the appropriateness of the ratings in ...
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half of 2026 Global Phase 3 LEVEL-2 Study Initiated; Company Estimates Completion of Enrollment by End of 2027 CHAPEL HILL, N.C., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clini...
Moody's Ratings (Moody's) has assigned an A3 rating of up to $500 million to Affiliated Managers Group, Inc.'s (AMG) newly issued senior unsecured notes. The proceeds from the offering will in part be used to redeem in full the $342 million convertible trust preferred securities due 2037, and for ge...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.